PlainPharmaWatch

CMS Open Payments · Tool

Jan Medical Inc. vs Brixton Biosciences, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Jan Medical Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 10,000, versus 1,756 for the other company. Its single largest recorded recipient represents 1.0% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Jan Medical Inc.
HHI 10,000 · top recipient 1.0%
Ranked #130 of 1,838 companies by HHI
Brixton Biosciences, Inc.
HHI 1,756 · top recipient 0.3%
Ranked #798 of 1,838 companies by HHI

Payment Overview

Company A

Jan Medical Inc.

Total Payments
$117.5K
% of Industry
0.0%
Transactions
7
Avg per Transaction
$16.8K
Recipients
6
Avg per Recipient
$19.6K
Payment Types
1
Top Payment Type
Consulting Fee
Total Payments
$117.6K
% of Industry
0.0%
Transactions
93
Avg per Transaction
$1.3K
Recipients
72
Avg per Recipient
$1.6K
Payment Types
3
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Jan Medical Inc. vs Brixton Biosciences, Inc. - total reported payments in CMS Open Payments PY2024

Brixton Biosciences, Inc.$117.6KJan Medical Inc.$117.5K

Payment Types Breakdown

Jan Medical Inc.

Consulting Fee $60.0K

51.0%

Brixton Biosciences, Inc.

Consulting Fee $30.4K

25.9%

Food and Beverage $5.0K

4.3%

Travel and Lodging $924.50

0.8%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Jan Medical Inc.

  1. 1

    Julian E Bailes Jr.

    $60,000.00 · 6 txns

Brixton Biosciences, Inc.

  1. 1

    MAXIM ECKMANN

    $12,183.09 · 9 txns

  2. 2

    ANIS DIZDAREVIC

    $7,500.00 · 5 txns

  3. 3

    ROBERT ROBERTS

    $3,088.55 · 1 txns

  4. 4

    BRIAN FULLER

    $2,129.19 · 2 txns

  5. 5

    IAN VALERIO

    $2,000.00 · 1 txns

Summary Comparison

Metric Jan Medical Inc. Brixton Biosciences, Inc.
Total Payments $117.5K $117.6K
% of Industry Total 0.0% 0.0%
Transaction Count 7 93
Avg per Transaction $16.8K $1.3K
Recipient Count 6 72
Avg per Recipient $19.6K $1.6K
Payment Type Count 1 3
Top Payment Type Consulting Fee Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.